Hi {{lead.First Name:default=edit me}},

Are you looking to capture a patient’s experience or disease history in biomarkers? Scientists at Pfizer have developed a new diagnostic for Sickle Cell Disease, partnering with Sanguine to collect blood and electronic patient-reported outcomes (ePROs). In-home collection enabled the discovery of predictive biomarkers tracking pain events occurring outside a medical setting, supporting patient stratification in clinical trials. Please let me know if you’d like to design a similar study for your research goals.

Sanguine Bio | Massachusetts

Schedule a Meeting
| www.sanguinebio.com